We are live on
!
Find out more
E Fund Management Portfolio holdings
AUM
$4.46B
Turnover
13.19%
This Fund
S&P 500
This Quarter
Est. Return
+29.65%
1 Year Est. Return
–
3 Year Est. Return
–
5 Year Est. Return
–
10 Year Est. Return
–
AUM
$1.58B
AUM Growth
+$264M
(+20%)
Cap. Flow
-$56.9M
Cap. Flow
% of AUM
-3.61%
Top 10 Holdings %
Top 10 Hldgs %
70.28%
Holding
330
New
38
Increased
107
Reduced
155
Closed
24
Avg Time Held
1.8
years
Top 10 Avg Time Held
0.8
years
Top 20 Avg Time Held
1.4
years
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
JOYY Inc
JOYY
|
+$3.5M |
| 2 |
Weibo
WB
|
+$2.7M |
| 3 |
iShares Core S&P 500 ETF
IVV
|
+$1.76M |
| 4 |
Hesai Group
HSAI
|
+$1.67M |
| 5 |
Structure Therapeutics
GPCR
|
+$1.64M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
STAAR Surgical
STAA
|
+$23.4M |
| 2 |
Yum China
YUMC
|
+$14M |
| 3 |
TSMC
TSM
|
+$8.84M |
| 4 |
Pinduoduo
PDD
|
+$8.79M |
| 5 |
Apple
AAPL
|
+$4.77M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Consumer Discretionary | 50.26% |
| 2 | Technology | 23.48% |
| 3 | Communication Services | 8.85% |
| 4 | Real Estate | 5.2% |
| 5 | Healthcare | 4.53% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | Held Since | |
|---|---|---|---|---|---|---|---|
201
Constellation Energy
CEG
$96.1B
| $373K | 0.02% |
3,189
-348
| -10% | -$40.6K |
2022 Q1
7 quarters
|
|
202
Denali Therapeutics
DNLI
$2.81B
| $371K | 0.02% |
17,290
+5,509
| +47% | +$109K |
2022 Q1
7 quarters
|
|
203
IDEAYA Biosciences
IDYA
$3.17B
| $369K | 0.02% |
+10,385
| New | +$310K |
2023 Q4
0 quarters
|
|
204
Fastenal
FAST
$58.5B
| $369K | 0.02% |
11,380
-1,184
| -9% | -$35.7K |
2021 Q1
11 quarters
|
|
205
TE Connectivity
TEL
$61.6B
| $368K | 0.02% |
2,622
-234
| -8% | -$30.1K |
2021 Q1
11 quarters
|
|
206
Bank of America
BAC
$358B
| $367K | 0.02% |
10,912
+123
| +1% | +$3.58K |
2021 Q1
11 quarters
|
|
207
DELISTED
Electronic Arts
EA
| $362K | 0.02% |
2,647
-294
| -10% | -$38.9K |
2021 Q1
11 quarters
|
|
208
Pool Corp
POOL
$6.27B
| $362K | 0.02% |
+907
| New | +$318K |
2023 Q4
0 quarters
|
|
209
DELISTED
Sage Therapeutics
SAGE
| $357K | 0.02% |
16,482
-4,678
| -22% | -$92.7K |
2022 Q1
7 quarters
|
|
210
Walmart Inc
WMT
$943B
| $357K | 0.02% |
6,786
+105
| +2% | +$5.56K |
2021 Q1
11 quarters
|
|
211
Exelon
EXC
$44.8B
| $356K | 0.02% |
9,913
-1,031
| -9% | -$39.7K |
2021 Q1
11 quarters
|
|
212
CoStar Group
CSGP
$13.1B
| $355K | 0.02% |
4,067
-425
| -9% | -$34.4K |
2022 Q4
4 quarters
|
|
213
Alibaba
BABA
$271B
| $348K | 0.02% |
4,488
-4,084
| -48% | -$325K |
2023 Q1
3 quarters
|
|
214
Verisk Analytics
VRSK
$24.8B
| $345K | 0.02% |
1,444
-152
| -10% | -$36K |
2021 Q1
11 quarters
|
|
215
Baker Hughes
BKR
$55.3B
| $342K | 0.02% |
10,019
-1,088
| -10% | -$37.1K |
2022 Q4
4 quarters
|
|
216
Xcel Energy
XEL
$47.7B
| $340K | 0.02% |
5,494
-571
| -9% | -$34.3K |
2021 Q1
11 quarters
|
|
217
McDonald's
MCD
$172B
| $339K | 0.02% |
1,143
+5
| +0.4% | +$1.36K |
2021 Q1
11 quarters
|
|
218
AstraZeneca
AZN
$257B
| $338K | 0.02% |
2,506
-242
| -9% | -$31.5K |
2022 Q1
7 quarters
|
|
219
Rocket Pharmaceuticals
RCKT
$239M
| $336K | 0.02% |
11,197
-1,215
| -10% | -$26.8K |
2022 Q3
5 quarters
|
|
220
DELISTED
Arcellx
ACLX
| $334K | 0.02% |
6,012
-2,144
| -26% | -$96.7K |
2023 Q1
3 quarters
|
|
221
DELISTED
Cerevel Therapeutics Holdings, Inc. Common Stock
CERE
| $322K | 0.02% |
7,599
-2,624
| -26% | -$75.4K |
2022 Q2
6 quarters
|
|
222
DELISTED
Catalyst Pharmaceutical
CPRX
| $318K | 0.02% |
18,913
-7,307
| -28% | -$99.9K |
2022 Q1
7 quarters
|
|
223
Atlassian
TEAM
$52.6B
| $317K | 0.02% |
1,334
-113
| -8% | -$22.2K |
2023 Q3
1 quarter
|
|
224
DoorDash
DASH
$82B
| $316K | 0.02% |
+3,191
| New | +$283K |
2023 Q4
0 quarters
|
|
225
Celldex Therapeutics
CLDX
$2.16B
| $315K | 0.02% |
7,949
-516
| -6% | -$15.2K |
2022 Q1
7 quarters
|
|
Similar funds
E Fund Management's Q4 2023 Portfolio in Review
As of Q4 2023, E Fund Management held 330 positions worth $1.58B, up 20% from $1.31B the previous quarter. Its ten largest holdings account for 70% of the portfolio.
E Fund Management withdrew a net $56.9M in Q4 2023, closing 24 positions and reducing 155 holdings. Its most notable exit was MINISO, an estimated $2.17M position sold in full.
By sector, the portfolio is most concentrated in Consumer Discretionary at 50% of assets, up from 45% a quarter earlier, followed by Technology and Communication Services.
Against the trend, E Fund Management opened a new position in Hesai Group worth $1.52M.
- E Fund Management's largest Q4 2023 buy was Hesai Group: 170,914 shares worth $1.52M.
- E Fund Management added most to JOYY Inc in Q4 2023, an estimated $3.5M increase.
- E Fund Management's biggest Q4 2023 reduction was STAAR Surgical, cutting an estimated $23.4M.
- E Fund Management fully exited MINISO in Q4 2023, selling an estimated $2.17M.
- E Fund Management's ten largest holdings make up 70% of its $1.58B portfolio in Q4 2023.
- E Fund Management opened 38 new positions and closed 24 in Q4 2023.
- E Fund Management's portfolio value rose 20% quarter-over-quarter to $1.58B.
Based on E Fund Management's 13F filing for Q4 2023, filed 7 Feb 2024.